Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

FEATURED PRODUCT
United States: Market Access Tracker

Annual fees related to the U.S. Affordable Care Act which will be levied on drug manufacturers will cost the pharmaceutical industry approximately $30.8 billion from 2011 through 2020... Learn More

WEBINAR ON DEMAND
Market Access in the Asia Pacific Region: The Impact of Drug Pricing Pressures and India’s Drastic Response

Recorded live on May 2, 2012 ...Learn More

View Webinar schedule and archive

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

Snapshot: AAN 2012
Physician Insight on Recent Developments in Multiple Sclerosis and New Data Presented at the 64th Annual Meeting of the American Academy of Neurology

Decision Resources finds that 90 percent of U.S. neurologists surveyed report a willingness to prescribe Biogen Idec’s BG-12 for the treatment of multiple sclerosis following the release of detailed results from the CONFIRM Phase III clinical trial, which were showcased at the 64th annual meeting of the American Academy of Neurology (AAN) in April 2012.

Recent Reports [ view all ]

  • Colorectal Cancer in Russia

    The incidence of colorectal cancer (CRC) in Russia is the highest among the BRIC (Brazil, Russia, India, China) markets... Read More

  • Hepatitis C Virus (Event Driven)

    Last Updated 17 May 2012
    Hepatitis C virus (HCV) is marked by a relatively large prevalent population and... Read More

  • Irritable Bowel Syndrome: Decision Resources' Market Forecast and Opportunity Analysis

    Irritable Bowel Syndrome: Decision Resources' Market Forecast and Opportunity Analysis is an Executive Summary... Read More

Decision Resources Group brands include: